Topical hemostatic agents are important adjuncts to reduce blood loss after cardiac surgery and can have a role in reducing both
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Topical Hemostatic Agents Market Size Growth Rate by Type (2019-2025)
1.3.2 Gelation Sponge
1.3.3 Oxidized Regenerated Cellulose Based Hemostats
1.3.4 Others
1.4 Market Segment by Application
1.4.1 Global Topical Hemostatic Agents Market Share by Application (2019-2025)
1.4.2 Hospitals
1.4.3 Surgical Centers
1.4.4 Nursing Homes
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Topical Hemostatic Agents Market Size
2.1.1 Global Topical Hemostatic Agents Revenue 2014-2025
2.1.2 Global Topical Hemostatic Agents Sales 2014-2025
2.2 Topical Hemostatic Agents Growth Rate by Regions
2.2.1 Global Topical Hemostatic Agents Sales by Regions 2014-2019
2.2.2 Global Topical Hemostatic Agents Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Topical Hemostatic Agents Sales by Manufacturers
3.1.1 Topical Hemostatic Agents Sales by Manufacturers 2014-2019
3.1.2 Topical Hemostatic Agents Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Topical Hemostatic Agents Revenue by Manufacturers (2014-2019)
3.2.2 Topical Hemostatic Agents Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Topical Hemostatic Agents Market Concentration Ratio (CR5 and HHI)
3.3 Topical Hemostatic Agents Price by Manufacturers
3.4 Key Manufacturers Topical Hemostatic Agents Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Topical Hemostatic Agents Market
3.6 Key Manufacturers Topical Hemostatic Agents Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Gelation Sponge Sales and Revenue (2014-2019)
4.1.2 Oxidized Regenerated Cellulose Based Hemostats Sales and Revenue (2014-2019)
4.1.3 Others Sales and Revenue (2014-2019)
4.2 Global Topical Hemostatic Agents Sales Market Share by Type
4.3 Global Topical Hemostatic Agents Revenue Market Share by Type
4.4 Topical Hemostatic Agents Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Topical Hemostatic Agents Sales by Application
6 United States
6.1 United States Topical Hemostatic Agents Breakdown Data by Company
6.2 United States Topical Hemostatic Agents Breakdown Data by Type
6.3 United States Topical Hemostatic Agents Breakdown Data by Application
7 European Union
7.1 European Union Topical Hemostatic Agents Breakdown Data by Company
7.2 European Union Topical Hemostatic Agents Breakdown Data by Type
7.3 European Union Topical Hemostatic Agents Breakdown Data by Application
8 China
8.1 China Topical Hemostatic Agents Breakdown Data by Company
8.2 China Topical Hemostatic Agents Breakdown Data by Type
8.3 China Topical Hemostatic Agents Breakdown Data by Application
9 Rest of World
9.1 Rest of World Topical Hemostatic Agents Breakdown Data by Company
9.2 Rest of World Topical Hemostatic Agents Breakdown Data by Type
9.3 Rest of World Topical Hemostatic Agents Breakdown Data by Application
9.4 Rest of World Topical Hemostatic Agents Breakdown Data by Countries
9.4.1 Rest of World Topical Hemostatic Agents Sales by Countries
9.4.2 Rest of World Topical Hemostatic Agents Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Ethicon
10.1.1 Ethicon Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Topical Hemostatic Agents
10.1.4 Topical Hemostatic Agents Product Introduction
10.1.5 Ethicon Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Topical Hemostatic Agents
10.2.4 Topical Hemostatic Agents Product Introduction
10.2.5 Pfizer Recent Development
10.3 Baxter International
10.3.1 Baxter International Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Topical Hemostatic Agents
10.3.4 Topical Hemostatic Agents Product Introduction
10.3.5 Baxter International Recent Development
10.4 C. R. Bard
10.4.1 C. R. Bard Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Topical Hemostatic Agents
10.4.4 Topical Hemostatic Agents Product Introduction
10.4.5 C. R. Bard Recent Development
10.5 The Medicines Company
10.5.1 The Medicines Company Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Topical Hemostatic Agents
10.5.4 Topical Hemostatic Agents Product Introduction
10.5.5 The Medicines Company Recent Development
10.6 Anika Therapeutics
10.6.1 Anika Therapeutics Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Topical Hemostatic Agents
10.6.4 Topical Hemostatic Agents Product Introduction
10.6.5 Anika Therapeutics Recent Development
10.7 Advanced Medical Solutions
10.7.1 Advanced Medical Solutions Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Topical Hemostatic Agents
10.7.4 Topical Hemostatic Agents Product Introduction
10.7.5 Advanced Medical Solutions Recent Development
10.8 Integra LifeSciences
10.8.1 Integra LifeSciences Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Topical Hemostatic Agents
10.8.4 Topical Hemostatic Agents Product Introduction
10.8.5 Integra LifeSciences Recent Development
10.9 B Braun Melsungen
10.9.1 B Braun Melsungen Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Topical Hemostatic Agents
10.9.4 Topical Hemostatic Agents Product Introduction
10.9.5 B Braun Melsungen Recent Development
10.10 Gelita Medical
10.10.1 Gelita Medical Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Topical Hemostatic Agents
10.10.4 Topical Hemostatic Agents Product Introduction
10.10.5 Gelita Medical Recent Development
10.11 Equimedical
10.12 Vascular Solutions
10.13 Marine Polymer Technologies
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Topical Hemostatic Agents Sales Channels
11.2.2 Topical Hemostatic Agents Distributors
11.3 Topical Hemostatic Agents Customers
12 Market Forecast
12.1 Global Topical Hemostatic Agents Sales and Revenue Forecast 2019-2025
12.2 Global Topical Hemostatic Agents Sales Forecast by Type
12.3 Global Topical Hemostatic Agents Sales Forecast by Application
12.4 Topical Hemostatic Agents Forecast by Regions
12.4.1 Global Topical Hemostatic Agents Sales Forecast by Regions 2019-2025
12.4.2 Global Topical Hemostatic Agents Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Topical Hemostatic Agents Market Size Growth Rate by Type (2019-2025)
1.3.2 Gelation Sponge
1.3.3 Oxidized Regenerated Cellulose Based Hemostats
1.3.4 Others
1.4 Market Segment by Application
1.4.1 Global Topical Hemostatic Agents Market Share by Application (2019-2025)
1.4.2 Hospitals
1.4.3 Surgical Centers
1.4.4 Nursing Homes
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Topical Hemostatic Agents Market Size
2.1.1 Global Topical Hemostatic Agents Revenue 2014-2025
2.1.2 Global Topical Hemostatic Agents Sales 2014-2025
2.2 Topical Hemostatic Agents Growth Rate by Regions
2.2.1 Global Topical Hemostatic Agents Sales by Regions 2014-2019
2.2.2 Global Topical Hemostatic Agents Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Topical Hemostatic Agents Sales by Manufacturers
3.1.1 Topical Hemostatic Agents Sales by Manufacturers 2014-2019
3.1.2 Topical Hemostatic Agents Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Topical Hemostatic Agents Revenue by Manufacturers (2014-2019)
3.2.2 Topical Hemostatic Agents Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Topical Hemostatic Agents Market Concentration Ratio (CR5 and HHI)
3.3 Topical Hemostatic Agents Price by Manufacturers
3.4 Key Manufacturers Topical Hemostatic Agents Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Topical Hemostatic Agents Market
3.6 Key Manufacturers Topical Hemostatic Agents Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Gelation Sponge Sales and Revenue (2014-2019)
4.1.2 Oxidized Regenerated Cellulose Based Hemostats Sales and Revenue (2014-2019)
4.1.3 Others Sales and Revenue (2014-2019)
4.2 Global Topical Hemostatic Agents Sales Market Share by Type
4.3 Global Topical Hemostatic Agents Revenue Market Share by Type
4.4 Topical Hemostatic Agents Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Topical Hemostatic Agents Sales by Application
6 United States
6.1 United States Topical Hemostatic Agents Breakdown Data by Company
6.2 United States Topical Hemostatic Agents Breakdown Data by Type
6.3 United States Topical Hemostatic Agents Breakdown Data by Application
7 European Union
7.1 European Union Topical Hemostatic Agents Breakdown Data by Company
7.2 European Union Topical Hemostatic Agents Breakdown Data by Type
7.3 European Union Topical Hemostatic Agents Breakdown Data by Application
8 China
8.1 China Topical Hemostatic Agents Breakdown Data by Company
8.2 China Topical Hemostatic Agents Breakdown Data by Type
8.3 China Topical Hemostatic Agents Breakdown Data by Application
9 Rest of World
9.1 Rest of World Topical Hemostatic Agents Breakdown Data by Company
9.2 Rest of World Topical Hemostatic Agents Breakdown Data by Type
9.3 Rest of World Topical Hemostatic Agents Breakdown Data by Application
9.4 Rest of World Topical Hemostatic Agents Breakdown Data by Countries
9.4.1 Rest of World Topical Hemostatic Agents Sales by Countries
9.4.2 Rest of World Topical Hemostatic Agents Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Ethicon
10.1.1 Ethicon Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Topical Hemostatic Agents
10.1.4 Topical Hemostatic Agents Product Introduction
10.1.5 Ethicon Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Topical Hemostatic Agents
10.2.4 Topical Hemostatic Agents Product Introduction
10.2.5 Pfizer Recent Development
10.3 Baxter International
10.3.1 Baxter International Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Topical Hemostatic Agents
10.3.4 Topical Hemostatic Agents Product Introduction
10.3.5 Baxter International Recent Development
10.4 C. R. Bard
10.4.1 C. R. Bard Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Topical Hemostatic Agents
10.4.4 Topical Hemostatic Agents Product Introduction
10.4.5 C. R. Bard Recent Development
10.5 The Medicines Company
10.5.1 The Medicines Company Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Topical Hemostatic Agents
10.5.4 Topical Hemostatic Agents Product Introduction
10.5.5 The Medicines Company Recent Development
10.6 Anika Therapeutics
10.6.1 Anika Therapeutics Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Topical Hemostatic Agents
10.6.4 Topical Hemostatic Agents Product Introduction
10.6.5 Anika Therapeutics Recent Development
10.7 Advanced Medical Solutions
10.7.1 Advanced Medical Solutions Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Topical Hemostatic Agents
10.7.4 Topical Hemostatic Agents Product Introduction
10.7.5 Advanced Medical Solutions Recent Development
10.8 Integra LifeSciences
10.8.1 Integra LifeSciences Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Topical Hemostatic Agents
10.8.4 Topical Hemostatic Agents Product Introduction
10.8.5 Integra LifeSciences Recent Development
10.9 B Braun Melsungen
10.9.1 B Braun Melsungen Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Topical Hemostatic Agents
10.9.4 Topical Hemostatic Agents Product Introduction
10.9.5 B Braun Melsungen Recent Development
10.10 Gelita Medical
10.10.1 Gelita Medical Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Topical Hemostatic Agents
10.10.4 Topical Hemostatic Agents Product Introduction
10.10.5 Gelita Medical Recent Development
10.11 Equimedical
10.12 Vascular Solutions
10.13 Marine Polymer Technologies
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Topical Hemostatic Agents Sales Channels
11.2.2 Topical Hemostatic Agents Distributors
11.3 Topical Hemostatic Agents Customers
12 Market Forecast
12.1 Global Topical Hemostatic Agents Sales and Revenue Forecast 2019-2025
12.2 Global Topical Hemostatic Agents Sales Forecast by Type
12.3 Global Topical Hemostatic Agents Sales Forecast by Application
12.4 Topical Hemostatic Agents Forecast by Regions
12.4.1 Global Topical Hemostatic Agents Sales Forecast by Regions 2019-2025
12.4.2 Global Topical Hemostatic Agents Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
